Inhibition of hepatitis B virus replication by stably expressed shRNA
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Author(s)
Detail(s)
Original language | English |
---|---|
Pages (from-to) | 398-404 |
Journal / Publication | Biochemical and Biophysical Research Communications |
Volume | 311 |
Issue number | 2 |
Publication status | Published - 14 Nov 2003 |
Externally published | Yes |
Link(s)
Abstract
The major challenges for anti-hepatitis B Virus (HBV) therapy are the low efficacy of current drugs and the occurrence of drug resistant HBV mutations. A drug with new target sites or independent metabolic pathways may overcome these shortcomings. Small interfering RNA (siRNA) offers the possibility of developing a new anti-HBV therapy. Here we describe the almost complete inhibition of HBV replication by stably expressed 21-mer short hairpin RNAs (shRNA). Besides the conventional targets on HBV reverse-transcriptase, we also systemically targeted other sites of pregenomic RNA, including direct repeat (DR) elements, S, core, and X gene. Our results indicated that shRNAs can serve as efficient alternative anti-HBV agents. They can also be used in combination with chemotherapy, because they showed better effects on the inhibition of HBV replication due to different mechanisms of drug actions. © 2003 Elsevier Inc. All rights reserved.
Research Area(s)
- Anti-HBV, Hepatitis B Virus, RNA interference, shRNA, U6 promoter
Citation Format(s)
Inhibition of hepatitis B virus replication by stably expressed shRNA. / Chen, Ying; Du, Dan; Wu, Jun et al.
In: Biochemical and Biophysical Research Communications, Vol. 311, No. 2, 14.11.2003, p. 398-404.
In: Biochemical and Biophysical Research Communications, Vol. 311, No. 2, 14.11.2003, p. 398-404.
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review